Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Merck to take $2.9 billion charge on hepatitis C drug
Merck to take $2.9 billion charge on hepatitis C drug
Merck to take $2.9 billion charge on hepatitis C drug
Submitted by
admin
on February 23, 2017 - 9:28pm
Source:
Marketwatch
News Tags:
Merck
hepatitis C
uprifosbuvir
Headline:
Merck to take $2.9 billion charge on hepatitis C drug
Do Not Allow Advertisers to Use My Personal information
